Low-Dose Versus High-Dose Cyclosporine Induction Protocols in Renal Transplantation

Transplantation Proceedings

Volumn 39, Issue 4, 2007, Pages 1219-1222

  Ghafari, A ^a   Makhdoomi, K ^a   Ahmadpour, P ^a   Afshari, A T ^a   Fallah, M M ^a   Rad, P S ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; PEPTIC ULCER; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SIDE EFFECT;

ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34248551687     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.03.014     Document Type: Article

References (8)

1. Sollinger H.W., and U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60 (1995) 225
2. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321
3. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61 (1996) 1029
4. Halloran P., Mathew T., Tomlanovich S., et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 63 (1997) 39
5. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions for nosocomial infections. Am J Infect Control 16 (1988) 128
6. Canafax D.M., Torres A., Fryd D.S., et al. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG azathioprine. Transplantation 41 (1986) 177
7. Barry J.M., Shively N., Hubert B., et al. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants. Transplantation 45 (1988) 346
8. Kahan B.D., Flechner S.M., Lorber M.I., et al. Complications of cyclosporin therapy. World J Surg 10 (1986) 348